Fiona Barry
Verified
As seen in:
GlobalData,
The Telegraph,
Yahoo Finance,
MDPI,
Veterinary Record,
Lexology,
FoodNavigator-USA,
Mondaq,
Pharmaceutical-Technology.com,
Clinical Trials Arena,
NutraIngredients
and
Covers:
Pharmaceuticals, health, business, culture, arts, society, comedy, feminism
Journo. Editor-in-Chief, GlobalData
Fiona.Barry@globaldata.com
Fiona.c.j.barry@gmail.com
Linkedin.com/in/fibarry
Get in touch with Fiona
Contact Fiona, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Fiona Barry’s Journalist Portfolio
See all 12 portfolio items →
US Election: In close race, tiny Senate majority, not President, will hold power - Pharmaceutical...
Fiona Barry - Editor-in-Chief at PharmSource / GlobalData talks to IBTV at Advanced Therapies Eur...
Articles
WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions Original
The Biosecure Act could still cut off US federal funding to pharma companies that outsource to WuXi AppTec. Geopolitics reportedly had little impact on WuXi AppTec in 2024. Credit: Andy.LIU / Shutterstock. WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.
PULSE: A Fast Portable Unit for Lab-on-Site Electrochemistry
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
WuXi Biologics’ CEO Chris Chen has denied that the company’s sale of its less than four-year-old Ireland site is due to the threat of the US Biosecure Act, and said that the number of new contracts is at an all-time “high”, while speaking at the JP Morgan (JPM) Annual Healthcare Conference 2025 on 15 January.
Actions
Get in touch with Fiona
Contact Fiona, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack